Browsing by Subject Antipsychotic drugs

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 39 of 39
Issue DateTitleAuthor(s)
2018Accessibility and safety of antipsychotics in the treatment of Autism Spectrum Disorder in children and adolescentsSadaf, Shaista
2018-10Accessibility and safety of antipsychotics in the treatment of autism spectrum disorder in children and adolescentsSadaf, Shaista; Mifsud Buhagiar, Luana; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony
2007Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D 2 receptors : a PET study in schizophreniaMizrahi, Romina; Rusjan, Pablo; Agid, Ofer; Graff-Guerrero, Ariel; Mamo, David; Zipursky, Robert B.; Kapur, Shitij
2010Analysis of antipsychotic dose reductionUchida, Hiroyuki; Suzuki, Takefumi; Takeuchi, Hiroyoshi; Mamo, David
2008The antipsychotic potential of l-stepholidine : a naturally occurring dopamine receptor D1 agonist and D2 antagonistNatesan, Sridhar; Reckless, Greg E.; Barlow, Karen B. L.; Odontiadis, John; Nobrega, Jose N.; Baker, Glen B.; George, Susan R.; Mamo, David; Kapur, Shitij
2013-06Antipsychotics and Aeds : therapeutic drug monitoring in a mental health care settingMifsud, Janet; Vella, T.; Ellul-Micallef, Roger
2010Are antipsychotic prescribing patterns different in older and younger adults? : a survey of 1357 psychiatric inpatients in TorontoSproule, Beth A.; Lake, Jennifer; Mamo, David; Uchida, Hiroyuki; Mulsant, Benoit H.
2002Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT2C receptors in vivoDi Matteo, Vincenzo; Cacchio, Marisa; Di Giulio, Camillo; Di Giovanni, Giuseppe; Esposito, Ennio
2015Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy : the missing link?Guiard, Bruno P.; Di Giovanni, Giuseppe
2012Defining treatment-resistant schizophrenia and response to antipsychotics : a review and recommendationSuzuki, Takefumi; Remington, Gary; Mulsant, Benoit H.; Uchida, Hiroyuki; Rajji, Tarek K.; Graff-Guerrero, Ariel; Mimura, Masaru; Mamo, David
2007Differential effects of aripiprazole on D 2, 5-HT 2, and 5-HT 1A receptor occupancy in patients with schizophrenia : a triple tracer PET studyMamo, David; Graff-Guerrero, Ariel; Mizrahi, Romina; Shammi, Chekkera M.; Romeyer, Franvoise; Kapur, Shitij
2015Dopamine D 2/3 receptor occupancy following dose reduction is predictable with minimal plasma antipsychotic concentrations : an open-label clinical trialNakajima, Shinichiro; Uchida, Hiroyuki; Bies, Robert R.; Caravaggio, Fernando; Suzuki, Takefumi; Plitman, Eric; Mar, Wanna; Gerretsen, Philip; Pollock, Bruce G.; Mulsant, Benoit H.; Mamo, David; Graff-Guerrero, Ariel
2012Dopamine D2 receptor occupancy and cognition in schizophrenia : analysis of the CATIE dataSakurai, Hitoshi; Bies, Robert R.; Stroup, Scott T.; Keefe, Richard S. E.; Rajji, Tarek K.; Suzuki, Takefumi; Mamo, David; Pollock, Bruce G.; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki
2012Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia : a cross-sectional studyMizuno, Yuya; Bies, Robert R.; Remington, Gary; Mamo, David; Suzuki, Takefumi; Pollock, Bruce G.; Tsuboi, Takashi; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki
2004Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6‐[18F]‐L‐m‐tyrosineMamo, David; Remington, Gary; Nobrega, Jose N.; Hussey, Doug; Chirakal, Raman; Wilson, Alan A.; Baker, Glen B.; Houle, Sylvain; Kapur, Shitij
2021The effectiveness of quetiapine in improving behavioural and psychological symptoms in older adults with dementiaXuereb, Crissel (2021)
2011Effects of aging on 5‐HT2AR binding : a HRRT PET study with and without partial volume correctionsUchida, Hiroyuki; Chow, Tiffany W.; Mamo, David; Kapur, Shitij; Mulsant, Benoit H.; Houle, Sylvain; Pollock, Bruce G.; Graff-Guerrero, Ariel
2013Estimated dopamine D2 receptor occupancy and remission in schizophrenia : analysis of the CATIE dataMoriguchi, Sho; Bies, Robert R.; Remington, Gary; Suzuki, Takefumi; Mamo, David; Watanabe, Koichiro; Mimura, Masaru; Pollock, Bruce G.; Uchida, Hiroyuki
2016Estimating the effect of endogenous dopamine on baseline [11C]‐(+)‐PHNO binding in the human brainCaravaggio, Fernando; Kegeles, Lawrence S.; Wilson, Alan A.; Remington, Gary; Borlido, Carol; Mamo, David; Graff-Guerrero, Ariel
2012Haloperidol for agitation in persons with dementia.Debono, Michael
2016Hearing voices : comparing the hearing voices approach with antipsychotic medication in adultsMicallef, Miriam
2006High-dose quetiapine and photopsiaHazra, Monica; Culo, Sandi; Mamo, David
2011Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophreniaHazra, Monica; Uchida, Hiroyuki; Sproule, Beth A.; Remington, Gary; Suzuki, Takefumi; Mamo, David
2009The intersection of pharmacology, imaging, and genetics in the development of personalized medicineGerretsen, Philip; Muller, Daniel J.; Tiwari, Arun; Mamo, David; Pollock, Bruce G.
2009Long-term stability of measuring D 2 receptors in schizophrenia patients treated with antipsychoticsUchida, Hiroyuki; Graff-Guerrero, Ariel; Mulsant, Benoit H.; Pollock, Bruce G.; Mamo, David
2004A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidoneMamo, David; Kapur, Shitij; Shammi, Chekkera M.; Papatheodorou, George; Mann, Steve; Therrien, Francois; Remington, Gary
2009Predicting age‐specific dosing of antipsychoticsUchida, Hiroyuki; Pollock, Bruce G.; Bies, Robert R.; Mamo, David
2012Predicting plasma concentration of risperidone associated with dosage change : a population pharmacokinetic studyUchida, Hiroyuki; Mamo, David; Pollock, Bruce G.; Suzuki, Takefumi; Tsunoda, Kenichi; Watanabe, Koichiro; Mimura, Masaru; Bies, Robert R.
2007Quantification of l-stepholidine in rat brain and plasma by high performance liquid chromatography combined with fluorescence detectionOdontiadis, John; MacKenzie, Erin M.; Natesan, Sridhar; Mamo, David; Kapur, Shitij; Baker, Glen B.
2009The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychoticsMizrahi, Romina; Mamo, David; Rusjan, Pablo; Graff, Ariel; Houle, Sylvain; Kapur, Shitij
2010Role of serotonin in central dopamine dysfunctionDi Giovanni, Giuseppe; Esposito, Ennio; Di Matteo, Vincenzo
2010Sensitivity to antipsychotic drugs in older adultsLeon, Chloe; Gerretsen, Philip; Uchida, Hiroyuki; Suzuki, Takefumi; Rajji, Tarek K.; Mamo, David
2015Serotonergic modulation of the activity of mesencephalic dopaminergic systems : therapeutic implicationsDe Deurwaerdère, Philippe; Di Giovanni, Giuseppe
2008Serotonin control of central dopaminergic function : focus on in vivo microdialysis studiesDi Matteo, Vincenzo; Di Giovanni, Giuseppe; Pierucci, Massimo; Esposito, Ennio
2023Serum prolactin monitoring in patients on risperidone admitted to the acute wards at Mount Carmel hospitalGambin, Rachel; Diacono, Sheriseane; Mizzi, Therese Ann; East, Rachel Taylor
2007Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response - a double-blind PET study in schizophreniaAgid, Ofer; Mamo, David; Ginovart, Nathalie; Vitcu, Irina; Wilson, Alan A.; Zipursky, Robert B.; Kapur, Shitij
2009Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT 2A) receptors in older, healthy adultsChow, Tiffany W.; Mamo, David; Uchida, Hiroyuki; Graff- Guerrero, Ariel; Houle, Sylvain; Smith, Gwenn S.; Pollock, Bruce G.; Mulsant, Benoit H.
2017Treating negative symptoms of schizophrenia : antipsychotics vs. antidepressants and antipsychoticsSaliba, Alexei Silvan
2010The use of antipsychotics in institutionalized elderly patients with dementiaBugeja, Vincent (2010)